Propafenone pharmacokinetics in uremic patients treated by peritoneal dialysis
Poirier, J.M.; Joannides, R.; Geffroy-Josse, S.; Fillastre, J.P.; Etienne, I.
Clinical Nephrology 38(4): 231-232
1992
ISSN/ISBN: 0301-0430 PMID: 1424311 Document Number: 399128
Document emailed within 1 workday
Related Documents
Shoji, T.; Nishizawa, Y.; Nishitani, H.; Yamakawa, M.; Morii, H. 1992: High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis Clinical Nephrology 38(5): 271-276Zhang, X.; Han, F.; He, Q.; Huang, H.; Yin, X.; Ge, J.; Chen, J. 2008: Outcomes and risk factors for mortality after transfer from hemodialysis to peritoneal dialysis in uremic patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 28(3): 313-314
Opatrná, S.; Racek, J.; Stehlík, P.; Senft, V.; Sefrna, F.; Topolcan, O.; Opatrný, K. 2002: Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis Casopis Lekaru Ceskych 141(9): 281-285
Jakić, M.; Stipanić, S.; Mihaljević, D.; Zibar, L.; Lovcić, V.; Klarić, D.; Jakić, M. 2005: The impact of glucose absorbed from dialysis solution on body weight gain in peritoneal dialysis treated patients Lijecnicki Vjesnik 127(5-6): 116-120
Chansritrakul, S.; Eiam-Ong, S.; Kansanabuch, T.; Wathanavaha, A.; Ruxrungtham, K. 2004: Continuous ambulatory peritoneal dialysis improves both the number and memory function of CD4 T cells in uremic patients Journal of the Medical Association of Thailand 87(4): 389-394
Sułowicz, W. 1990: Activity of some lysosomal enzymes in peritoneal macrophages of patients with end-stage renal failure treated by intermittent peritoneal dialysis Folia Haematologica 117(5): 663-667
Krediet, R.T. 2001: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(6): 560-567
Kaiser, G.; Gál, G.; Mészáros, E. 1975: Transfusion-immunization in uremic patients treated by chronic dialysis Orvosi Hetilap 116(11): 604-607
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Chan, M.K.; Chau, P.Y.; Chan, W.W. 1987: Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis Clinical Nephrology 28(6): 277-280
Manley, H.J.; Bailie, G.R.; Asher, R.D.; Eisele, G.; Frye, R.F. 1999: Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(1): 65-70
Zharfbin, A. 2006: Dyslipidemia in patients being treated with peritoneal dialysis Vnitrni Lekarstvi 52(11): 1051-1057
Sifil, A.; Mermut, C.; Yenicerioglu, Y.; Cavdar, C.; Gumustekin, M.; Celik, A.; Yuksel, F.; Camsari, T. 2003: Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 28-30
Makulska, I.; Zwolińska, D.; Kiliś-Pstrusińska, K.; Magier, K. 2001: Nutritional status of children treated with continuous ambulatory peritoneal dialysis and ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(58): 219-223
El-Matri, A.; Ben Dridi, M.; Ben Ayed, H. 1978: Treatment of uremic pericarditis by episodic peritoneal dialysis La Nouvelle Presse Medicale 7(38): 3457
Tomino, Y.; Fukui, M.; Hamada, C.; Inoue, S.; Osada, S. 1998: Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis Arzneimittel-Forschung 48(8): 862-867
Bistrup, C.; Siboni, A.H.; Pedersen, R.S. 1995: Peritonitis among patients treated with continuous ambulatory peritoneal dialysis Ugeskrift for Laeger 157(28): 4023-4026
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203
Kanjanabuch, T.; Puttipittayathorn, N.; Leelahavanichkul, A.; Lieusuwan, S.; Katavetin, P.; Mahatanan, N.; Sriudom, K.; Chirananthavat, T.; Thongbor, N.; Eiam-Ong, S. 2011: Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients Journal of the Medical Association of Thailand 94(Suppl 4): S119-S125
Oba, I.; Mori, T.; Chida, M.; Kurasawa, N.; Naganuma, E.; Sato, E.; Koizumi, K.; Sato, S.; Tsuchikawa, M.; Ito, S. 2015: Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 31: 11-16